Marengo Therapeutics Secures Second FDA Fast Track Designation for Invikafusp Alfa, Broadening Its Scope to High Tumor Mutational Burden Solid Tumors #USA #Cambridge #FDA_Fast_Track #Marengo_Therapeutics #Invikafusp_Alfa